- Anheuser-Busch InBev SA BUD reported second-quarter FY21 sales growth of 31.5% year-on-year, to $13.54 billion, beating the analyst consensus of $13.54 billion.
- On an organic basis, the top-line grew by 27.6%, comprised 20.8% volume and 5.8% revenue per hl growth.
- Combined revenues of three brands, Budweiser, Stella Artois, and Corona, rose 23.0% Y/Y.
- Gross profit expanded 31.1% organically to $7.8 billion, and gross margin increased 152 basis points to 57.8%.
- Normalized EBITDA for the quarter increased 31% organically to $4.8 billion.
- Cash flow from operating activities amounted to $3.9 billion in the half-year period. Net debt totaled $83.4 billion as of 30 June 2021.
- It reported an Underlying EPS of $0.75 and Normalized EPS of $0.95, versus the consensus of $0.83.
- Outlook: Anheuser-Busch InBev reiterated its EBITDA outlook to grow 8-12% for FY21 and its revenue to grow ahead of EBITDA from a healthy combination of volume and price.
- Price action: BUD shares are trading lower by 5.33% at $64.97 in premarket on the last check Thursday.
- Photo by clementejunio from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in